EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prescribing Patterns in Pediatric Hidradenitis Suppurativa

Hannah Neimy iD, Courtney L Walker, Lara Wine Lee iD, Colleen H Cotton

Pediatric Dermatology · 2025

DOI: 10.1111/pde.70129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Hannah Neimy und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Practice Patterns, Physicians'. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is an inflammatory skin condition increasingly diagnosed in pediatric populations; however, data on treatment practices in this group remains limited. In this retrospective study of 163 patients diagnosed with HS ≤ 18 years of age, we found that treatment patterns varied significantly by disease severity. As compared to patients with Hurley stage I (HSI) disease, those with Hurley stage III (HSIII) were more likely to receive: biologics (11.8% versus 58.3%, p < 0.001), chlorhexidine (47.1% versus 75.0%, p = 0.009), intralesional steroid injections (20.0% versus 58.3%, p < 0.001), metformin (3.53% versus 22.2%, p = 0.006), oral steroids (0%, versus 19.4%, p < 0.001), and spironolactone (10.6% versus 38.9%, p = 0.001). Higher Hurley stage was also associated with higher odds of receiving pain management prescriptions (NSAIDs [10.6% HSI versus 26.2% Hurley stage II (HSII) versus 52.8% HSIII; p < 0.001] and opioids [3.6% HSI versus 9.3% HSII versus 31.0% HSIII; p < 0.001]).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaPractice Patterns, Physicians'HumansRetrospective StudiesChildMaleFemaleAdolescentSeverity of Illness IndexChild, PreschoolDrug PrescriptionsBiological Products

Stichwörter der Autor:innen

hidradenitis suppurativapainretrospectivetreatment

Substanzen

Biological Products

Autor:innen und Institutionen

  • College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • College of Graduate Studies, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Dermatology & Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Division of Dermatology, Children's National Hospital, Washington, District of Columbia, USA.
  • Department of Dermatology, George Washington School of Medicine and Health Sciences, Washington, District of Columbia, USA.

ORCID-Profile: Hannah Neimy, Lara Wine Lee

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Neimy, H., Walker, C. L., Lee, L. W., & Cotton, C. H. (2025). Prescribing Patterns in Pediatric Hidradenitis Suppurativa. Pediatric Dermatology. https://doi.org/10.1111/pde.70129

Vancouver

Neimy H, Walker CL, Lee LW, Cotton CH. Prescribing Patterns in Pediatric Hidradenitis Suppurativa. Pediatric Dermatology. 2025. doi:10.1111/pde.70129

BibTeX
@article{Neimy2025,
  author = {Neimy, Hannah and Walker, Courtney L and Lee, Lara Wine and Cotton, Colleen H},
  title = {Prescribing Patterns in Pediatric Hidradenitis Suppurativa},
  journal = {Pediatric Dermatology},
  year = {2025},
  doi = {10.1111/pde.70129}
}
Kostenlos starten →